ERBB2 and breast cancer: The SPECT imaging demonstrates that 99mTc-PEG24-RDH6 can specifically distinguish HER2-positive tumors from HER2-negative tumors with better imaging contrast, indicating that the 99mTc-PEG24-RDH6 has the potential for clinical screening of HER2-positive BC.